Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients

Circulation

Volumn 94, Issue 4, 1996, Pages 704-707

  Hosoi, Masayuki ^a   Nishizawa, Yoshiki ^a   Kogawa, Kyoko ^a   Kawagishi, Takahiko ^a   Konishi, Toshiaki ^a   Maekawa, Kiyoshi ^a   Emoto, Masanori ^a   Fukumoto, Shinya ^a   Shioi, Atsushi ^a   Shoji, Tetsuo ^a   Inaba, Masaaki ^a   Okuno, Yasuhisa ^a   Morii, Hirotoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

atherosclerosis; diabetes mellitus; genetics

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY INTIMA; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DISEASE ASSOCIATION; FEMALE; FEMORAL ARTERY; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

EID: 9544240358     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.704     Document Type: Article

References (19)

1. Lonn E, Yusuf S, Jha PMT, Teo K, Benedict C, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;90:2056-2069.
2. Rigat B, Hubert C, Alhenc GF, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
3. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
4. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994;91:3662-3665.
5. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T. A potent genetic risk factor for restenosis. Nat Genet. 1993;5:324-325.
6. Marre M, Bernadet P, Gallon's Y, Savagner F, Guyene T-T, Hallab M, Cambien F, Passa P, Alhene-Gelas F. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 1994;43:384-388.
7. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H, High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820-826.
8. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem. 1981;27:1922-1925.
9. Wendelhag I, Wiklund O, Wikstrand J, Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb, 1993;13:1404-1411.
10. Kawasaki ES. Sample preparation from blood cells, and other fluids. In: PCR Protocols. San Diego, Calif: Academic Press, Inc; 1990:146-152.
11. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
12. Fujisawa T, Ikegami H, Shen G-Q, Yamato E, Takekawa E, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J, Ohishi M, Fujii K, Fukuda M, Ogihara T. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care. 1995;18: 983-985.
13. Wofford J, Kahl F, Howard G, McKinney W, Toole J, Grouse JI. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786-1794.
14. Castellano M, Muiesan M, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M, Porteri E, Betoni G, Kreutz R, Lindpaintner K, Rosei E. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population: the Vobarno study. Circulation. 1995;91:2721-2724.
15. Sternby N. Atherosclerosis in a defined population: an autopsy survey in Malmö, Sweden. Acta Pathol Microbiol Scand. 1968;194(suppl I):111-118.
16. Cooper M, Rumble J, Komers R, He-Cheng D, Jandeleit K, Sheung-To C. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes. 1994;43:1221-1228.
17. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
18. Johnston C. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994;23:258-268.
19. Danser JAH, Schalekamp MADH, Bax WA, van der Brink AM, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387-1388.